SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy’s Laboratories informs about disclosure

20 Sep 2024 Evaluate
Dr. Reddy’s Laboratories has informed that the United States Food & Drug Administration (USFDA) today completed a routine Good Manufacturing Practice (GMP) inspection at its R&D centre (Integrated Product Development Organisation or IPDO) in Bachupally, Hyderabad. The inspection was conducted from 16th September to 20th September, 2024. The inspection closed with zero observations.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1318.00 -15.05 (-1.13%)
24-Apr-2026 09:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1653.00
Dr. Reddys Lab 1318.00
Cipla 1268.00
Zydus Lifesciences 939.60
Lupin 2335.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×